seribantumab
elevation oncology
['crest', 'sclc', 'nsclc', 'lcsm,(-blcsm)']
dr daniel carrizosa presents important initial safety and efficacy data on crestone phase 2 study for nrg1fusion #nsclc patients. a deep and durable response seen, well tolerated, promising results for a yet untargeted driver mutation. more studies underway. #asco22 #lcsm 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.